|
|
Gyrasol Technologies, based in Santa Fe, NM, was formed in 2007 to meet biopharmaceutical researchers' urgent need for expertly designed drug selection assays. Gyrasol's scientific team has broad expertise in developing and commercializing assays for molecular drug targets, and flexibility in solving customers' difficult assay problems.
Please contact us to discuss our assay development services and products. We specialize in assays for the emerging drug discovery targets: lipid and DNA kinases and other difficult, novel, and proprietary drug targets, optimized for target validation or high-throughput screening.
9/2/2008 BioTek Instruments and Gyrasol Technologies Enter Marketing Agreement
11/1/2009 GEN article: Cellular-Signaling Pathway Signatures Measuring Various Post-Translational Modifications with One Detection Reagent |
|
|
Your Shopping Cart is Empty
|
|
|
